Cure Ventures
Liang Chang is a Senior Associate at Aditum Bio, contributing to biotech venture capital focused on translating scientific innovations into accessible medicines. Previously, Liang served as an Associate at Cure Ventures and as a Fellow at both 5AM Ventures and Flagship Pioneering, specializing in biotech investment and company formation. Liang's research experience includes a Ph.D. at the Broad Institute of MIT and Harvard, focusing on cancer functional genomics. Additional roles included Senior Business Development Fellow at Harvard University's Office of Technology Development, co-founder and writer for the biotech blog Biodraft_, and a research assistant at MD Anderson Cancer Center. Liang holds degrees from Harvard University and MIT, as well as a Bachelor's degree from Macalester College.
This person is not in the org chart
This person is not in any teams
Cure Ventures
Cure Ventures is a venture firm focused on investing in the life sciences and medical technologies. We aim to propel novel cures to market by discovering and enabling biotechnology, pharmaceutical, medical device, and medtech firms with exceptional growth potential committed to addressing unmet medical needs for global patient targets.